Ribavirin aerosol: methods for reducing employee exposure

Area of Science:

• Environmental Health
• Occupational Safety
• Pharmaceutical Aerosol Management

Background:

• Ribavirin is an antiviral medication often administered via aerosol.
• Healthcare environments, particularly pediatric intensive care units, may have elevated ribavirin aerosol concentrations.
• Minimizing occupational exposure to ribavirin aerosol is recommended due to potential health risks.

Purpose of the Study:

• To evaluate the efficacy of two novel exhaust control methods for reducing ribavirin aerosol.
• To quantify the reduction in ribavirin concentration in patient breathing zones versus general room air.
• To review existing control strategies and environmental monitoring data for ribavirin.

Main Methods:

• Implementation of two distinct exhaust control systems in pediatric intensive care rooms.
• Collection and analysis of air samples to measure ribavirin concentrations.
• Comparison of airborne ribavirin levels in patient breathing zones and general room air.

Main Results:

• Both exhaust control methods achieved a 99.9% reduction in ribavirin aerosol concentration.
• Average room air concentrations were significantly lower (37-64 µg/m³) compared to patient breathing zone concentrations (45,000-58,000 µg/m³).
• A safe occupational exposure limit was calculated at 91 µg/m³ (8-hour time-weighted average).

Conclusions:

• The evaluated exhaust control methods are highly effective in reducing airborne ribavirin.
• Significant reduction in occupational exposure is achievable with appropriate engineering controls.
• Further research and adherence to exposure limits are necessary to ensure healthcare worker safety.